Omnicell (OMCL) closed at $37.15 on Aug 4, 2026, down 1.3% on the day. The stock is down 17.9% over the past month, down 14.5% over three months, down 18.0% year to date and up 24.8% over the past year. It trades 32.5% below its 52-week high of $55.00 and 17.0% above its 52-week low of $31.75. The close sits below its 50-day moving average ($41.82) and below its 200-day moving average ($40.43).
Over its last 8 reports the stock moved an average of 15.6% on the first trading day after earnings, beating the options-implied move in 5 of 8.
Over the last 8 reports, OMCL moved an average of 15.6% on the first trading day after earnings. The move beat the options-implied move in 5 of 8 reports.
No — the Aug 4, 2026 close of $37.15 is 8.1% below the 200-day average of $40.43.
OMCL closed 32.5% below its 52-week high of $55.00.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
